. "62" . "Mrkvan, Tom\u00E1\u0161" . "Indukce syst\u00E9mov\u00E9 resistence proti n\u00E1doru pomoc\u00ED c\u00EDlen\u00FDch polymer\u016F"@cs . "Polymer HPMA-based conjugates containing cytotoxic drugs have an anti-cancer activity together with a protective effect towards the anti-tumor immune responses. In mice after the tumor treatment (EL-4, BCL1, 38C13), a long-lasting, systemic resistance against the tumor occurs" . "Ulbrich, Karel" . . "Induction of Systemic Antitumour Resistance with Targered Polymers"@en . . "1" . "[6C2510A2F8FC]" . . "Indukce syst\u00E9mov\u00E9 resistence proti n\u00E1doru pomoc\u00ED c\u00EDlen\u00FDch polymer\u016F"@cs . . "100;105" . "Indukce syst\u00E9mov\u00E9 resistence proti n\u00E1doru pomoc\u00ED c\u00EDlen\u00FDch polymer\u016F Anot.: Polymern\u00ED konjug\u00E1ty na b\u00E1zi HPMA s nav\u00E1zan\u00FDm cytostatikem maj\u00ED protin\u00E1dorovou aktivitu a nepo\u0161kozuj\u00ED p\u0159itom imunitn\u00ED syst\u00E9m obrany proti n\u00E1dor\u016Fm. U my\u0161\u00ED se po vyl\u00E9\u010Den\u00ED n\u00E1doru (EL-4, BCL1, 38C13) projevuje dlouhodob\u011B p\u0159etrv\u00E1vaj\u00EDc\u00ED resistence proti n\u00E1doru"@cs . . . . "Induction of Systemic Antitumour Resistance with Targered Polymers" . "0300-9475" . "\u0160\u00EDrov\u00E1, Milada" . . "Scandinavian Journal of Immunology" . . "\u0160ubr, Vladim\u00EDr" . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "10"^^ . . . "Induction of Systemic Antitumour Resistance with Targered Polymers"@en . "6"^^ . "\u0158\u00EDhov\u00E1, Blanka" . . "Induction of Systemic Antitumour Resistance with Targered Polymers" . "5"^^ . . "RIV/61388971:_____/05:00022939" . "Strohalm, Ji\u0159\u00ED" . "524594" . "Rozprimov\u00E1, L." . . . . . "Hovorka, Ond\u0159ej" . "Kov\u00E1\u0159, Marek" . . "RIV/61388971:_____/05:00022939!RIV06-AV0-61388971" . "Kub\u00E1\u010Dkov\u00E1, K." . "Polymer HPMA-based conjugates containing cytotoxic drugs have an anti-cancer activity together with a protective effect towards the anti-tumor immune responses. In mice after the tumor treatment (EL-4, BCL1, 38C13), a long-lasting, systemic resistance against the tumor occurs"@en . "P(GA305/02/1425), P(GD310/03/H147), Z(AV0Z5020903)" . "HPMA; systemic antitumour resistance; targered polymers"@en .